Thorium and Actinium Polyphosphonate Compounds As Bone-seeking Alpha Particle-emitting Agents

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 101-105

  Henriksen, Gjermund ^a,b   Bruland, Øyvind S ^c   Larsen, Roy H ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b Algeta ASA   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

particles; Actinium; Osseous neoplasms; Thorium

Indexed keywords

ACTINIUM; ACTINIUM 1,4,7,10 TETRAAZACYCLODODECANE N,N',N'',N''' 1,4,7,10 TETRAMETHYLENEPHOSPHONIC ACID AC 228; PHOSPHINIC ACID DERIVATIVE; THORIUM 1,4,7,10 TETRAAZACYCLODODECANE N,N',N'',N''' 1,4,7,10 TETRAMETHYLENEPHOSPHONIC ACID TH 227; THORIUM DERIVATIVE; THORIUM DIETHYLENETRIAMINE N,N',N'' PENTAMETHYLENEPHOSPHONIC ACID TH 227; UNCLASSIFIED DRUG;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; CANCER RADIOTHERAPY; CHEMICAL REACTION; CONTROLLED STUDY; DEMETALLATION; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; FEMUR; KIDNEY; LIVER; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE; TISSUE DISTRIBUTION; TISSUE LEVEL;

ACTINIUM; ALPHA PARTICLES; ANIMALS; BONE AND BONES; FEMUR; KIDNEY; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; RADIOPHARMACEUTICALS; THORIUM; TISSUE DISTRIBUTION;

EID: 1442351111     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Silberstein EB: The treatment of painful osseous metastases with phosphorous-32 labeled phosphates. Semin Oncol 20: 10-21,1993.
2. Ackery D and Yardley J: Radionuclide-targeted therapy for the management of metastatic bone pain. Semin Oncol 20 (Suppl. 2): 27-31,1993.
3. Silberstein EB Editorial: Dosage and response in radiopharmaceutical therapy of painful osseous metastases. J Nucl Med 37: 249-252, 1996.
4. Bouchet LG, Bolch WE, Goddu SM, Howell RW and Rao DV: Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions. J Nucl Med 41: 682-687, 2000.
5. Goddu SM, Bishayee A, Bouchet LG, Bolch WE, Rao DV and Howell RW: Marrow toxicity of P-33- versus P-32-orthophosphate: Implications for therapy of bone pain and bone metastases. J Nucl Med 41: 941-951, 2000.
6. Krishnamurthy GT and Krishnamurthy S: Radionuclides for metastatic bone pain palliation: A need for rational re-evaluation in the new millennium. J Nucl Med 41: 688-691, 2000.
7. Collins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, Livingston RB, Gordon EE, Chapman CR and Appelbaum FR: Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: A phase I/II trial. J Nucl Med 34: 1839-1844, 1993.
8. Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD and Harrison KA: Palliation of pain associated with metastatic bone cancer using Samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16: 1574-1581, 1998.
9. Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga RC, Smith H, Moulton JS, Williams CC, Ehrhardt GJ and Schneider HJ: Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. J Nucl Med 32: 1877-1881, 1991.
10. de Klerk JMH, van Dijk A, van het Schip AD, Zonnenberg BA and van Rijk PP: Pharmacokinetics of Rhenium-186 after administration of Rhenium-186-HEDP to patients with bone metastases. J Nucl Med 33: 646-651, 1992.
11. Atkins HL, Mausner LF, Srivastava SC, Meinken GE, Cabahug CJ and D'Alessandro T: Tin-117m(4+)-DTPA for palliation of pain from osseous metastases: a pilot study. J Nucl Med 36: 725-729,1995.
12. Srivastava SC, Atkins HL, Krishnamurthy GT, Zanzi I, Silberstein EB, Meinken G, Mausner LF, Swailem F, D'Alessandro T, Cabahug CJ, Lau Y, Park T and Madajewicz S: Treatment of metastatic bone pain with Tin-117m Stannic diethylenetriaminepentaacetic acid: A phase I/II clinical study. Clin Cancer Res 4: 61-68, 1998.
13. Silberstein EB Editorial: Dosage and response in radiopharmaceutical therapy of painful osseous metastases. J Nucl Med 37: 249-252, 1996.
14. Hall EJ: Radiology for the Radiologist 4th ed. J.B. Lippincott Co. Philadelphia, 1994, pp153-164.
15. 131I-labeled bisphosphonates with high in vivo stability and bone accumulation. J Nucl Med 40: 1197-1203, 1999.
16. 212Bi-EDTMP-synthesis and biodistribution of a novel bone seeking alpha-emitting radiopharmaceutical. J Labeled Compds Radiopharm 34: 717-734, 1994.
17. 212Bi-DOTMP- An alpha particle emitting bone seeking agent for targeted radiotherapy. Nucl Med Biol 24: 231-237, 1997.
18. 223Ra demonstrated in an experimental skeletal metastases model. Cancer Res 62: 3120-3125, 2002.
19. 89Sr in mice. J Nucl Med 44: 252-259, 2003.
20. Taylor DM: The metabolism of actinium in the rat. Health Phys 19: 411-418, 1970.
21. Müller WA: Studies on short-lived internal α-emitters in mice and rats. Part II. 227Th. Int J Radiat Biol 20: 233-243, 1971.
22. Goeckeler WF, Edwards B, Volkert WA, Holmes RA, Simon J and Wilson D: Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. J Nucl Med 28: 495-504, 1987.
23. Bayouth JE, Macey DJ, Boyer AL and Champlin RE: Radiation dose distribution within the bone marrow of patients receiving holmium-166-labeled-phosphonate for marrow ablation. Med Phys 22: 743-753, 1994.
24. Bruland ØS, Skretting A, Solheim OP and Aas M: Targeted radiotherapy of osteosarcoma using 153Sm-EDTMP. A new promising approach. Acta Oncol 35: 381-384, 1996.
25. Volkert WA and Hoffmann TJ: Therapeutic radiopharmaceuticals. Chem Rev 99: 2269-2292, 1999.
26. Müller WA: Präparative arbeiten über 227Ac und seine Folgeprodukte. Radiochim Acta 9: 181-186, 1968.
27. Narbutt J and Bilewicz A: Gamma emitting radiotracers Ra-224, Pb-212 and Bi-212 from natural thorium. Appl Radiat Isot 49: 89-91, 1998.
28. 225actinium chelates: Tissue distribution and radiotoxicity. Nucl Med Biol 26: 581-589, 1999.
29. 225Ac in tumor-bearing mice. Nucl Med Biol 24: 367-372,1997.